Buckled Manhattan Columns Lacked Required Reinforcements

An investigation into a structural failure at the former Pfizer headquarters in Midtown Manhattan has revealed that two buckled steel columns likely lacked the steel reinforcement plates required by approved building plans, according to engineering reviews of construction drawings and photographic evidence. The incident, which triggered mass evacuations and raised fears of a localized collapse, has sparked multiple investigations and renewed scrutiny of New York City’s construction oversight system.

The Incident

On July 7, 2026, workers discovered that two structural steel columns had buckled on the 21st floor of 235 East 42nd Street — the former Pfizer world headquarters undergoing the largest office-to-residential conversion in city history. The building, a 37-story steel-frame structure built in the 1970s, was being converted into 1,600 luxury apartments by developer MetroLoft.

According to the New York Post, Mayor Zohran Mamdani described the situation as “extremely serious,” confirming the building was “shifting” and “unstable.” FDNY Chief John Esposito warned that while a total collapse was unlikely, a “localized collapse” remained possible. Eight to nine neighboring buildings were evacuated, including a school and the Israeli consulate, and a frozen zone was established from East 40th to 45th Streets between First and Third Avenues.

Missing Reinforcements

The core question at the heart of the investigation is whether the failed columns ever received the steel reinforcement plates specified in the approved structural plans. The New York Times reported on July 16 that engineers who examined both the approved drawings and photographs of the buckled columns found no evidence the plates had been added. The reinforcement was required for 13 stories between the 9th and 21st floors — directly beneath a 10-story addition that widened the upper floors.

Notably, the NYC Department of Buildings initially posted a complaint summary explicitly blaming a “failure to provide steel reinforcement as per approved plans,” but deleted that line the same day, calling it an “inaccurate” entry by a staff member. The DOB has declined to confirm whether the reinforcing was properly completed.

Structural engineer Eric Cowley told Gothamist that the extent of deformation was far beyond what would be expected if reinforcement was in place, describing the damage as “a total failure” and “an amazing amount of deformation.” Chris Cerino, past president of the Structural Engineers Association of New York, questioned how such a lapse could escape quality control: “If reinforcing plates were missed, how did this escape quality control and special inspections?”

Developer’s Response

MetroLoft founder Nathan Berman told the Wall Street Journal on July 8 that the two columns “may not have been properly reinforced” and suggested that added weight from widening the top 15 floors likely caused the damage. However, he insisted the building’s overall integrity was not compromised, calling the incident a “freak accident.”

“Ninety-five percent of the building, the structure is sound and intact,” Berman said. “There is no way that this corner of a small extension all of a sudden topples this building.”

Wider Investigations

The incident has triggered multiple investigations. The NYC Department of Buildings, the Manhattan District Attorney’s Office, and the NYC Department of Investigation are all probing the failure. According to The Real Deal, the DOB has ordered inspectors to conduct safety reviews of construction sites across the city, targeting projects involving the same companies linked to the Pfizer building conversion.

The general contractor, 235 GC LLC, had accumulated seven DOB violations at the site prior to the incident, including falling metal and glass and a worker falling from a ladder. The special inspection agency, Domani Inspection Services, also had prior violations against its inspector.

Implications for NYC’s Conversion Boom

The incident has cast a shadow over New York City’s booming office-to-residential conversion trend, which has been promoted as a solution to both the post-COVID office vacancy crisis and the city’s housing shortage. As of early 2024, NYC had 44 completed, ongoing, or potential conversion projects totaling 15.2 million square feet, with the Pfizer project serving as a flagship.

Gary LaBarbera, president of the NYC Buildings and Construction Trades Council, said the violations are “indicative of someone looking to cut corners.” Structural engineers have noted that adaptive reuse projects present unique challenges, and questions are being raised about whether conversion projects receive adequate structural review.

What’s Next

Emergency shoring has been installed across 29 floors, and the building has been declared stable. However, engineers say the buckled columns will likely need to be removed and replaced entirely. Four nearby buildings remain under partial evacuation orders.

The investigations will determine whether criminal charges are filed and whether reforms to the special inspection system are needed. The outcome could have lasting implications for how New York City oversees its largest construction projects — and whether the office-to-residential conversion trend can continue at its current pace.